Clinical Trials Directory

Trials / Unknown

UnknownNCT05410665

The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Nanjing First Hospital, Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to evaluate the roles of IL-9/E-cadheirin and ferroptosis in the intestinal mucosal barrier injury of sepsis. The results of this study would lay the foundation for revealing the mechanisms of EEN improving immune imbalance of sepsis and provide a new idea to the early treatment of sepsis.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard treatments for sepsisStandard treatments for others

Timeline

Start date
2022-05-31
Primary completion
2023-12-31
Completion
2024-06-30
First posted
2022-06-08
Last updated
2022-06-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05410665. Inclusion in this directory is not an endorsement.

The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis (NCT05410665) · Clinical Trials Directory